Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Plusquellec

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Medical Engineering & Physics|September 5, 1998
Local identifiability for two and three-compartment pharmacokinetic models with time-lagsJ A Merino, J De Biasi, Y Plusquellec, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1991
Decrease in albendazole sulphonation during experimental fascioliasis in sheepP Galtier, M Alvinerie, Y Plusquellec, et al.
Journal of Pharmaceutical Sciences|May 1, 1989
A pharmacokinetic model for intraperitoneal administration of drugs: application to teniposide in humansP Canal, Y Plusquellec, E Chatelut, et al.
Journal of Pharmaceutical Sciences|January 1, 1991
Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to albendazole in sheepP Galtier, M Alvinerie, J L Steimer, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1987
A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorptionY Plusquellec, G Campistron, S Staveris, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Journal of Pharmaceutical Sciences|October 1, 1992
Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administrationY Plusquellec, J Barre, J de Biasi, et al.
Journal of Pharmaceutical Sciences|August 1, 1991
Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in childrenE Chatelut, H Roche, Y Plusquellec, et al.
Arzneimittel-Forschung|May 9, 1998
Enterohepatic recirculation of the new antihypertensive drug UP 269-6 in humans. A possible model to account for multiple plasma peaksY Plusquellec, R Arnaud, S Saivin, et al.
Arzneimittel-Forschung|September 1, 1994
Evidence for a second site of absorption of veralipride in the human small intestine. Use of a new drug delivery telemetric shuttleS Staveris, G Houin, A Dufour, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Medical Engineering & Physics|September 5, 1998
Local identifiability for two and three-compartment pharmacokinetic models with time-lagsJ A Merino, J De Biasi, Y Plusquellec, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1991
Decrease in albendazole sulphonation during experimental fascioliasis in sheepP Galtier, M Alvinerie, Y Plusquellec, et al.
Journal of Pharmaceutical Sciences|May 1, 1989
A pharmacokinetic model for intraperitoneal administration of drugs: application to teniposide in humansP Canal, Y Plusquellec, E Chatelut, et al.
Journal of Pharmaceutical Sciences|January 1, 1991
Simultaneous pharmacokinetic modeling of a drug and two metabolites: application to albendazole in sheepP Galtier, M Alvinerie, J L Steimer, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1987
A double-peak phenomenon in the pharmacokinetics of veralipride after oral administration: a double-site model for drug absorptionY Plusquellec, G Campistron, S Staveris, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1989
Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26)P Canal, R Bugat, E Chatelut, et al.
Journal of Pharmaceutical Sciences|October 1, 1992
Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administrationY Plusquellec, J Barre, J de Biasi, et al.
Journal of Pharmaceutical Sciences|August 1, 1991
Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in childrenE Chatelut, H Roche, Y Plusquellec, et al.
Arzneimittel-Forschung|May 9, 1998
Enterohepatic recirculation of the new antihypertensive drug UP 269-6 in humans. A possible model to account for multiple plasma peaksY Plusquellec, R Arnaud, S Saivin, et al.
Arzneimittel-Forschung|September 1, 1994
Evidence for a second site of absorption of veralipride in the human small intestine. Use of a new drug delivery telemetric shuttleS Staveris, G Houin, A Dufour, et al.
Pageof 4